GLP-1 Drugs Found to Cut Alcohol Consumption and Improve Mental Health

New research presented at the European Congress on Obesity highlights the potential of GLP-1 receptor agonists to reduce alcohol intake by nearly two-thirds and enhance mood and quality of life in obese adults.